Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 14;96(9):900-907.
doi: 10.1136/jnnp-2024-335037.

Predictors of early disability accumulation in newly diagnosed multiple sclerosis: clinical, imaging and cerebrospinal fluid measures

Affiliations

Predictors of early disability accumulation in newly diagnosed multiple sclerosis: clinical, imaging and cerebrospinal fluid measures

Markus Lauerer et al. J Neurol Neurosurg Psychiatry. .

Abstract

Background: A growing arsenal of treatment options for relapsing multiple sclerosis (RMS) emphasises the need for early prognostic biomarkers. While evidence for individual markers exists, comprehensive analyses at the time of diagnosis are sparse.

Methods: Brain and spinal cord lesion numbers, cerebrospinal fluid parameters, initial symptoms, and Expanded Disability Status Scale (EDSS) score were determined at the time of diagnosis. Confirmed disability accumulation (CDA), defined as a sustained EDSS increase over 6 months, was determined during a 5-year follow-up. All-subsets multivariable logistic regression was performed to identify predictors of CDA. Model performance was assessed via receiver operating characteristic analysis, and individual risks were calculated. Analyses were repeated with progression independent of relapse activity (PIRA) as an outcome.

Results: 113/417 (27.1%) people with RMS experienced CDA on follow-up. Intrathecal IgG synthesis, a higher number of spinal cord lesions, age and polysymptomatic manifestation were identified as independent predictors of CDA. The resulting prediction model yielded an area under the curve (AUC) of 0.75 with a 95% CI of 0.70 to 0.80. Individuals exceeding the optimal thresholds for the three most significant predictors had a 61.8% likelihood of experiencing CDA, whereas those below all three thresholds had a CDA rate of 4.5%. The only significant baseline predictor differentiating PIRA from relapse-associated worsening was a higher number of spinal cord lesions (AUC=0.64, 95% CI 0.54 to 0.74).

Conclusions: Intrathecal IgG synthesis, spinal cord lesion number, age and polysymptomatic manifestation are independent predictors of early CDA in newly diagnosed RMS.

Keywords: CLINICAL NEUROLOGY; CSF; MRI; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None of the authors have reported conflicts of interest directly related to this study. KG has received reimbursement for traveling expenses from UCB and Viatris. AB has received consulting and/or speaker fees from Alexion, Biogen, Celgene, Horizon, Novartis, Roche and Sandoz/Hexal. His institution has received compensation for clinical trials from Alexion, Biogen, Merck, Novartis, Roche and Sanofi Genzyme. JSK has received speaker fees for Novartis. He is a shareholder of Bonescreen. BH has served on scientific advisory boards for Novartis; he has served as DMSC member for AllergyCare, Sandoz, Polpharma, Biocon and TG therapeutics; his institution received research grants from Roche for multiple sclerosis research. He has received honoraria for counselling (Gerson Lehrmann Group). He holds part of two patents; one for the detection of antibodies against KIR4.1 in a subpopulation of patients with multiple sclerosis and one for genetic determinants of neutralising antibodies to interferon.

Figures

Figure 1
Figure 1. Participant flow chart. CDA, confirmed disability accumulation; CSF, cerebrospinal fluid; PIRA, progression independent of relapse activity; RAW, relapse-associated worsening; RMS, relapsing multiple sclerosis.
Figure 2
Figure 2. Receiver operating characteristic curves for different prediction models with confirmed disability accumulation as an outcome. Full model: including all 12 potential predictors; reduced model: including only significant predictors identified by all-subsets regression (number of spinal cord lesions, intrathecal IgG synthesis, age, polysymptomatic manifestation). A curve for IgG index as a surrogate for intrathecal IgG synthesis was added since the latter’s dichotomous nature prevents it from being displayed this way. AUC, area under the curve; n, number.
Figure 3
Figure 3. Survival curves based on optimal thresholds for the three main predictors of CDA. (A) Survival curves of four subgroups based on the number of threshold values exceeded. RRs were calculated in reference to the group without any predictor above threshold. (B) Survival curves of the one and two thresholds groups further stratified by the specific predictors exceeding their respective threshold. + and − denote whether individuals in a group exceed the respective threshold for a variable or not (or are positive for an attribute or not in the case of intrathecal IgG synthesis). The y-axis has been cropped for better discrimination of the curves. Threshold values were calculated using Youden’s method: SC lesion number >1, age >38 years. CDA, confirmed disability accumulation; ref., reference; RR, relative risk; SC, spinal cord.

References

    1. Weinshenker BG, Rice GP, Noseworthy JH, et al. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain (Bacau) 1991;114 (Pt 2):1045–56. doi: 10.1093/brain/114.2.1045. - DOI - PubMed
    1. Reeve K, On BI, Havla J, et al. Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis. Cochrane Database Syst Rev. 2023;9:CD013606. doi: 10.1002/14651858.CD013606.pub2. - DOI - PMC - PubMed
    1. Uher T, Vaneckova M, Sobisek L, et al. Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis. Mult Scler. 2017;23:51–61. doi: 10.1177/1352458516642314. - DOI - PubMed
    1. Chung KK, Altmann D, Barkhof F, et al. A 30-Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes. Ann Neurol. 2020;87:63–74. doi: 10.1002/ana.25637. - DOI - PMC - PubMed
    1. Pisani AI, Scalfari A, Crescenzo F, et al. A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients. Eur J Neurol. 2021;28:2503–12. doi: 10.1111/ene.14859. - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources